<annotation text="Summary PurposeIntravitreal ranibizumab or bevacizumab are the most used drugs for treatment of neovascular age-related macular degeneration (nAMD). Repeated intravitreal injections represent an economic burden and may be associated with serious complications. The aim of this study is to evaluate the number of needed injections within 1 year of treatment. Methods55 patients over 50 years of age with nAMD and visual acuity (VA) between 20/40 and 20/320 were included. Scheduled visits and treatment were performed monthly for 1 year. After a loading dose of three intravitreal injections (either ranibizumab = group 1 or bevacizumab = group 2), an “as needed” regimen was performed. Primary endpoint was a difference in the injection frequencies of ranibizumab and bevacizumab. Secondary endpoints were best corrected visual acuity (BCVA) and central retinal thickness (CRT). ResultsDifference in number of injections was not significant (5.00 ± 1.67 (ranibizumab group) vs. 5.80 ± 2.28 (bevacizumab group), p = 0.084). Mean BCVA was 59.12 ± 16.64 letters after 12 months if patients received ranibizumab (p = 0.001) and 64.75 ± 17.03 letters if patients received bevacizumab (p = 0.037). There was no statistical significance between the two groups (p = 0.631). The mean CRT did not differ significantly between groups after 12 months (315.67 ± 65.86 µm for ranibizumab, 350.47 ± 102.84 µm for bevacizumab, p = 0.088). ConclusionThere was no difference in number of treatment, BCVA and CRT after 1 year between ranibizumab and bevacizumab in patients with nAMD.">
  <surfaceForm name="drugs" offset="73">
    <resource label="Pharmaceutical drug" uri="Pharmaceutical_drug" contextualScore="0.48459185517683667" percentageOfSecondRank="1.8128279314427734E-4" support="3024" priorScore="2.5153699166715508E-5" finalScore="0.16089837531600976" types=""/>
    <resource label="Drug" uri="Drug" contextualScore="0.5141943142979093" percentageOfSecondRank="0.19175917183900773" support="4759" priorScore="3.958546770317431E-5" finalScore="0.8390648216351951" types=""/>
  </surfaceForm>
  <surfaceForm name="injections" offset="319">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.9999999808387658" percentageOfSecondRank="2.8615101138770074E-9" support="361" priorScore="3.002806018248776E-6" finalScore="0.9999999971378202" types=""/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="624">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="group" offset="967">
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.3773733152683559" percentageOfSecondRank="0.012571064276363474" support="9593" priorScore="7.979478707218977E-5" finalScore="0.9870969994868769" types=""/>
  </surfaceForm>
  <surfaceForm name="group" offset="1003">
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.3773733152683559" percentageOfSecondRank="0.012571064276363474" support="9593" priorScore="7.979478707218977E-5" finalScore="0.9870969994868769" types=""/>
  </surfaceForm>
  <surfaceForm name="groups" offset="1246">
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.3773944105743439" percentageOfSecondRank="0.03470450101961311" support="9593" priorScore="7.979478707218977E-5" finalScore="0.9651642767435061" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="1362">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="991">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="endpoint" offset="694">
    <resource label="Clinical endpoint" uri="Clinical_endpoint" contextualScore="0.036818351226802666" percentageOfSecondRank="1.4382024065201242E-7" support="43" priorScore="3.576749550822642E-7" finalScore="0.1166730503319082" types=""/>
  </surfaceForm>
  <surfaceForm name="number" offset="1460">
    <resource label="Number" uri="Number" contextualScore="0.9885178193721101" percentageOfSecondRank="1.6568098193637116E-4" support="2343" priorScore="1.948912604087779E-5" finalScore="0.9996845653044468" types=""/>
  </surfaceForm>
  <surfaceForm name="group 2" offset="638">
    <resource label="Alkaline earth metal" uri="Alkaline_earth_metal" contextualScore="0.2236736051734437" percentageOfSecondRank="0.014362848326642523" support="246" priorScore="2.0462334639589996E-6" finalScore="0.9832815792596826" types=""/>
  </surfaceForm>
  <surfaceForm name="visual acuity" offset="821">
    <resource label="Visual acuity" uri="Visual_acuity" contextualScore="1.0" percentageOfSecondRank="4.178435981561969E-22" support="457" priorScore="3.8013361505254586E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="Mean" offset="1023">
    <resource label="Mean" uri="Mean" contextualScore="0.3122958609462864" percentageOfSecondRank="0.01381702379686506" support="2513" priorScore="2.0903189816784415E-5" finalScore="0.9860501992121262" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="752">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="difference" offset="1446">
    <resource label="Subtraction" uri="Subtraction" contextualScore="0.905559781537005" percentageOfSecondRank="0.029424123027765238" support="412" priorScore="3.4270251510207636E-6" finalScore="0.971174774684977" types=""/>
  </surfaceForm>
  <surfaceForm name="There" offset="1192">
    <resource label="France" uri="France" contextualScore="0.9344796267642265" percentageOfSecondRank="1.1081138463449113E-4" support="205641" priorScore="0.0017105264055365555" finalScore="0.9998839750449132" types="Schema:Place, DBpedia:Place, DBpedia:PopulatedPlace, Schema:Country, DBpedia:Country"/>
  </surfaceForm>
  <surfaceForm name="VA" offset="427">
    <resource label="United States Department of Veterans Affairs" uri="United_States_Department_of_Veterans_Affairs" contextualScore="0.934628226715764" percentageOfSecondRank="1.3184996150934138E-4" support="1211" priorScore="1.0073124897781904E-5" finalScore="0.2623632693811938" types="DBpedia:Agent, Schema:Organization, DBpedia:Organisation, Schema:GovernmentOrganization, DBpedia:GovernmentAgency"/>
    <resource label="Virginia" uri="Virginia" contextualScore="0.05726665712353492" percentageOfSecondRank="0.3557000425536785" support="56009" priorScore="4.658841060279659E-4" finalScore="0.7375969580931402" types="Schema:Place, DBpedia:Place, DBpedia:PopulatedPlace, DBpedia:Region, Schema:AdministrativeArea, DBpedia:AdministrativeRegion"/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="43">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="received" offset="1087">
    <resource label="Organ transplantation" uri="Organ_transplantation" contextualScore="0.9928753263582446" percentageOfSecondRank="0.0037194003224190965" support="1133" priorScore="9.4243191653071E-6" finalScore="0.996288025110321" types=""/>
  </surfaceForm>
  <surfaceForm name="Scheduled" offset="471">
    <resource label="Scheduled monument" uri="Scheduled_monument" contextualScore="0.9020590833250758" percentageOfSecondRank="0.0029514086849015404" support="1562" priorScore="1.2992750693918525E-5" finalScore="0.9970570003075578" types=""/>
  </surfaceForm>
  <surfaceForm name="CRT" offset="873">
    <resource label="Cathode ray tube" uri="Cathode_ray_tube" contextualScore="0.9852311166570441" percentageOfSecondRank="2.3599434287143874E-5" support="1115" priorScore="9.274594765505223E-6" finalScore="0.9999751614615698" types=""/>
  </surfaceForm>
  <surfaceForm name="injections" offset="580">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.9999999808387658" percentageOfSecondRank="2.8615101138770074E-9" support="361" priorScore="3.002806018248776E-6" finalScore="0.9999999971378202" types=""/>
  </surfaceForm>
  <surfaceForm name="CRT" offset="1275">
    <resource label="Cathode ray tube" uri="Cathode_ray_tube" contextualScore="0.9852311166570441" percentageOfSecondRank="2.3599434287143874E-5" support="1115" priorScore="9.274594765505223E-6" finalScore="0.9999751614615698" types=""/>
  </surfaceForm>
  <surfaceForm name="group 1" offset="613">
    <resource label="List of IARC Group 1 carcinogens" uri="List_of_IARC_Group_1_carcinogens" contextualScore="0.999099177308181" percentageOfSecondRank="0.006525490271632028" support="34" priorScore="2.8281275518132515E-7" finalScore="0.9916097185482743" types=""/>
  </surfaceForm>
  <surfaceForm name="complications" offset="246">
    <resource label="Complication (medicine)" uri="Complication_(medicine)" contextualScore="0.001394571673181407" percentageOfSecondRank="0.21984705942644686" support="401" priorScore="3.3355269066973936E-6" finalScore="0.16378957965891694" types=""/>
    <resource label="Adverse effect" uri="Adverse_effect" contextualScore="0.9918150622062644" percentageOfSecondRank="0.2046853521901302" support="887" priorScore="7.3780857013481E-6" finalScore="0.8002017628832298" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="955">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="age" offset="394">
    <resource label="Ageing" uri="Ageing" contextualScore="0.9995648734002843" percentageOfSecondRank="1.069070753377138E-5" support="1877" priorScore="1.561292769045139E-5" finalScore="0.9999893033529157" types=""/>
  </surfaceForm>
  <surfaceForm name="frequencies" offset="737">
    <resource label="Frequency" uri="Frequency" contextualScore="0.8721972990303992" percentageOfSecondRank="1.5378543169918148E-4" support="8484" priorScore="7.057010043995184E-5" finalScore="0.9997476378396215" types=""/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="1398">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="injections" offset="910">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.9999999808387658" percentageOfSecondRank="2.8615101138770074E-9" support="361" priorScore="3.002806018248776E-6" finalScore="0.9999999971378202" types=""/>
  </surfaceForm>
  <surfaceForm name="groups" offset="1316">
    <resource label="Group (mathematics)" uri="Group_(mathematics)" contextualScore="0.3773944105743439" percentageOfSecondRank="0.03470450101961311" support="9593" priorScore="7.979478707218977E-5" finalScore="0.9651642767435061" types=""/>
  </surfaceForm>
  <surfaceForm name="received" offset="1158">
    <resource label="Organ transplantation" uri="Organ_transplantation" contextualScore="0.9928753263582446" percentageOfSecondRank="0.0037194003224190965" support="1133" priorScore="9.4243191653071E-6" finalScore="0.996288025110321" types=""/>
  </surfaceForm>
  <surfaceForm name="performed" offset="675">
    <resource label="Performing arts" uri="Performing_arts" contextualScore="0.5252705241175725" percentageOfSecondRank="0.011770729102365917" support="1679" priorScore="1.3965959292630733E-5" finalScore="0.1721393497494035" types=""/>
    <resource label="Performance" uri="Performance" contextualScore="0.37218349268556256" percentageOfSecondRank="0.2085555899747972" support="1794" priorScore="1.492253184692051E-5" finalScore="0.8253883282160195" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="368">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999873783737" percentageOfSecondRank="7.223401522351967E-12" support="2793" priorScore="2.323223603592474E-5" finalScore="0.999999999992724" types=""/>
  </surfaceForm>
  <surfaceForm name="retinal" offset="854">
    <resource label="Retina" uri="Retina" contextualScore="0.9999998271489553" percentageOfSecondRank="4.8347788751363644E-11" support="2219" priorScore="1.8457691286687073E-5" finalScore="0.999999999951001" types="DBpedia:AnatomicalStructure"/>
  </surfaceForm>
  <surfaceForm name="economic" offset="195">
    <resource label="Economy" uri="Economy" contextualScore="0.22951502842068394" percentageOfSecondRank="0.0014156938429413062" support="5590" priorScore="4.649774416069434E-5" finalScore="0.25701606995538534" types=""/>
    <resource label="Economics" uri="Economics" contextualScore="0.671757667706611" percentageOfSecondRank="0.34613521470635905" support="13254" priorScore="1.1024706638744951E-4" finalScore="0.7425308348745238" types=""/>
  </surfaceForm>
  <surfaceForm name="number" offset="302">
    <resource label="Number" uri="Number" contextualScore="0.9885178193721101" percentageOfSecondRank="1.6568098193637116E-4" support="2343" priorScore="1.948912604087779E-5" finalScore="0.9996845653044468" types=""/>
  </surfaceForm>
  <surfaceForm name="performed" offset="507">
    <resource label="Performing arts" uri="Performing_arts" contextualScore="0.5252705241175725" percentageOfSecondRank="0.011770729102365917" support="1679" priorScore="1.3965959292630733E-5" finalScore="0.1721393497494035" types=""/>
    <resource label="Performance" uri="Performance" contextualScore="0.37218349268556256" percentageOfSecondRank="0.2085555899747972" support="1794" priorScore="1.492253184692051E-5" finalScore="0.8253883282160195" types=""/>
  </surfaceForm>
  <surfaceForm name="µm" offset="1355">
    <resource label="Micrometre" uri="Micrometre" contextualScore="0.9994669861405092" percentageOfSecondRank="2.5642333549818603E-6" support="1532" priorScore="1.2743210027582062E-5" finalScore="0.999997426178781" types=""/>
  </surfaceForm>
  <surfaceForm name="After" offset="537">
    <resource label="Myst" uri="Myst" contextualScore="0.9878576937012423" percentageOfSecondRank="0.0075469293373333435" support="606" priorScore="5.04072145999656E-6" finalScore="0.9920983886238973" types="Schema:CreativeWork, DBpedia:Work, DBpedia:Software, DBpedia:VideoGame"/>
  </surfaceForm>
  <surfaceForm name="µm" offset="1391">
    <resource label="Micrometre" uri="Micrometre" contextualScore="0.9994669861405092" percentageOfSecondRank="2.5642333549818603E-6" support="1532" priorScore="1.2743210027582062E-5" finalScore="0.999997426178781" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="1149">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999873783737" percentageOfSecondRank="7.223401522351967E-12" support="2793" priorScore="2.323223603592474E-5" finalScore="0.999999999992724" types=""/>
  </surfaceForm>
  <surfaceForm name="CRT" offset="1490">
    <resource label="Cathode ray tube" uri="Cathode_ray_tube" contextualScore="0.9852311166570441" percentageOfSecondRank="2.3599434287143874E-5" support="1115" priorScore="9.274594765505223E-6" finalScore="0.9999751614615698" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="1096">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="difference" offset="709">
    <resource label="Subtraction" uri="Subtraction" contextualScore="0.905559781537005" percentageOfSecondRank="0.029424123027765238" support="412" priorScore="3.4270251510207636E-6" finalScore="0.971174774684977" types=""/>
  </surfaceForm>
  <surfaceForm name="Primary" offset="686">
    <resource label="Primary school" uri="Primary_school" contextualScore="0.03891944787744576" percentageOfSecondRank="0.18195625961122913" support="5147" priorScore="4.28128603211259E-5" finalScore="0.10654712575403726" types=""/>
    <resource label="Primary education" uri="Primary_education" contextualScore="0.9502085321923842" percentageOfSecondRank="0.12320848647084039" support="2081" priorScore="1.7309804221539342E-5" finalScore="0.8647709975664187" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="599">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="1531">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="patients" offset="1078">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999873783737" percentageOfSecondRank="7.223401522351967E-12" support="2793" priorScore="2.323223603592474E-5" finalScore="0.999999999992724" types=""/>
  </surfaceForm>
  <surfaceForm name="letters" offset="1051">
    <resource label="Letter (alphabet)" uri="Letter_(alphabet)" contextualScore="0.08921631562861321" percentageOfSecondRank="0.09156544247628691" support="1541" priorScore="1.2818072227483002E-5" finalScore="0.8798939072385789" types=""/>
  </surfaceForm>
  <surfaceForm name="The" offset="1266">
    <resource label="Joseph Stalin" uri="Joseph_Stalin" contextualScore="0.4029167471753016" percentageOfSecondRank="0.04155130394770899" support="6340" priorScore="5.273626081910593E-5" finalScore="0.37817943039132185" types="DBpedia:Agent, Schema:Person, Http://xmlns.com/foaf/0.1/Person, DBpedia:Person, DBpedia:OfficeHolder"/>
    <resource label="English articles" uri="English_articles" contextualScore="0.006216999867125708" percentageOfSecondRank="0.6277137626081692" support="5094" priorScore="4.237200514393148E-5" finalScore="0.6024711467532193" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="1515">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="1167">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="differ" offset="1287">
    <resource label="Sexual dimorphism" uri="Sexual_dimorphism" contextualScore="0.9550745028410113" percentageOfSecondRank="0.020626478063094186" support="1925" priorScore="1.6012192756589734E-5" finalScore="0.9791489191389919" types=""/>
  </surfaceForm>
  <surfaceForm name="patients" offset="1546">
    <resource label="Patient" uri="Patient" contextualScore="0.9999999873783737" percentageOfSecondRank="7.223401522351967E-12" support="2793" priorScore="2.323223603592474E-5" finalScore="0.999999999992724" types=""/>
  </surfaceForm>
  <surfaceForm name="number" offset="900">
    <resource label="Number" uri="Number" contextualScore="0.9885178193721101" percentageOfSecondRank="1.6568098193637116E-4" support="2343" priorScore="1.948912604087779E-5" finalScore="0.9996845653044468" types=""/>
  </surfaceForm>
  <surfaceForm name="age-related macular degeneration" offset="108">
    <resource label="Macular degeneration" uri="Macular_degeneration" contextualScore="1.0" percentageOfSecondRank="0.0" support="411" priorScore="3.418707128809548E-6" finalScore="1.0" types="DBpedia:Disease"/>
  </surfaceForm>
  <surfaceForm name="visual acuity" offset="412">
    <resource label="Visual acuity" uri="Visual_acuity" contextualScore="1.0" percentageOfSecondRank="4.178435981561969E-22" support="457" priorScore="3.8013361505254586E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="injection" offset="727">
    <resource label="Intramuscular injection" uri="Intramuscular_injection" contextualScore="0.9371863608264576" percentageOfSecondRank="0.047283006249576424" support="219" priorScore="1.8216468642561826E-6" finalScore="0.9547006286466696" types=""/>
  </surfaceForm>
  <surfaceForm name="statistical significance" offset="1205">
    <resource label="Statistical significance" uri="Statistical_significance" contextualScore="1.0" percentageOfSecondRank="0.0" support="596" priorScore="4.957541237884406E-6" finalScore="1.0" types=""/>
  </surfaceForm>
  <surfaceForm name="ranibizumab" offset="28">
    <resource label="Ranibizumab" uri="Ranibizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="40" priorScore="3.3272088844861784E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="bevacizumab" offset="768">
    <resource label="Bevacizumab" uri="Bevacizumab" contextualScore="1.0" percentageOfSecondRank="0.0" support="112" priorScore="9.316184876561299E-7" finalScore="1.0" types="DBpedia:Drug"/>
  </surfaceForm>
  <surfaceForm name="injections" offset="171">
    <resource label="Injection (medicine)" uri="Injection_(medicine)" contextualScore="0.9999999808387658" percentageOfSecondRank="2.8615101138770074E-9" support="361" priorScore="3.002806018248776E-6" finalScore="0.9999999971378202" types=""/>
  </surfaceForm>
  <surfaceForm name="letters" offset="1138">
    <resource label="Letter (alphabet)" uri="Letter_(alphabet)" contextualScore="0.08921631562861321" percentageOfSecondRank="0.09156544247628691" support="1541" priorScore="1.2818072227483002E-5" finalScore="0.8798939072385789" types=""/>
  </surfaceForm>
  <surfaceForm name="central" offset="846">
    <resource label="Central nervous system" uri="Central_nervous_system" contextualScore="0.9999999999332658" percentageOfSecondRank="7.57958979693551E-12" support="2481" priorScore="2.063701310602552E-5" finalScore="0.9999999999868123" types=""/>
  </surfaceForm>
  <surfaceForm name="represent" offset="182">
    <resource label="Representation (mathematics)" uri="Representation_(mathematics)" contextualScore="0.9217745797675448" percentageOfSecondRank="0.014805937109258887" support="119" priorScore="9.89844643134638E-7" finalScore="0.9714627539367671" types=""/>
  </surfaceForm>
</annotation>